Angiography Injectors Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : December 2019 Pages : 170 Category: Medical Devices Report Code : HC127295
Angiography Injectors Market by Type (Dual-head, Single-head) Application (Cardiac Macrovascular Disease, Central Nervous System Disease, Peripheral Vascular Disease) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Angiography Injectors Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality. These devices control contrast dosage, record the amount used, speed injections to keep up with fast CT scanners, and warn of potential hazards, such as air embolisms or extravasations.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer AG (Medrad Inc.)
- GE Healthcare
- Vivid Imaging
- Bracco Imaging
- Ulrich
- Guerbet Group
- Nemoto Kyorindo
- Apollo RT
- Sino Medical-Device Technology
- Angiodynamics (Navilyst Medical)
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Angiography Injectors Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Dual-head
o Single-head
· Angiography Injectors Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cardiac Macrovascular Disease
o Central Nervous System Disease
o Peripheral Vascular Disease
· Angiography Injectors Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Bayer AG (Medrad Inc.)
o GE Healthcare
o Vivid Imaging
o Bracco Imaging
o Ulrich
o Guerbet Group
o Nemoto Kyorindo
o Apollo RT
o Sino Medical-Device Technology
o Angiodynamics (Navilyst Medical)
· Angiography Injectors Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Angiography Injectors Market, By Country
o U.S. Angiography Injectors Market
o Canada Angiography Injectors Market
o Mexico Angiography Injectors Market
o Europe
§ Europe Angiography Injectors Market, By Country
· Germany Angiography Injectors Market
o UK Angiography Injectors Market
o France Angiography Injectors Market
o Russia Angiography Injectors Market
o Italy Angiography Injectors Market
o Rest of Europe Angiography Injectors Market
o Asia-Pacific
§ Asia-Pacific Angiography Injectors Market, By Country
o China Angiography Injectors Market
o Japan Angiography Injectors Market
o South Korea Angiography Injectors Market
o India Angiography Injectors Market
o Southeast Asia Angiography Injectors Market
o Rest of Asia-Pacific Angiography Injectors Market
o South America
§ South America Angiography Injectors Market
o Brazil Angiography Injectors Market
o Argentina Angiography Injectors Market
o Columbia Angiography Injectors Market
o Rest of South America Angiography Injectors Market
o Middle East and Africa
§ Middle East and Africa Angiography Injectors Market
o Saudi Arabia Angiography Injectors Market
o UAE Angiography Injectors Market
o Egypt Angiography Injectors Market
o Nigeria Angiography Injectors Market
o South Africa Angiography Injectors Market
o Rest of MEA Angiography Injectors Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Angiography Injectors Market, By Type
5.1. Introduction
5.2. Global Angiography Injectors Revenue and Market Share by Type (2017-2027)
5.2.1. Global Angiography Injectors Revenue and Revenue Share by Type (2017-2027)
5.3. Dual-head
5.3.1. Global Dual-head Revenue and Growth Rate (2017-2027)
5.4. Single-head
5.4.1. Global Single-head Revenue and Growth Rate (2017-2027)
6. Angiography Injectors Market, By Application
6.1. Introduction
6.2. Global Angiography Injectors Revenue and Market Share by Application (2017-2027)
6.2.1. Global Angiography Injectors Revenue and Revenue Share by Application (2017-2027)
6.3. Cardiac Macrovascular Disease
6.3.1. Global Cardiac Macrovascular Disease Revenue and Growth Rate (2017-2027)
6.4. Central Nervous System Disease
6.4.1. Global Central Nervous System Disease Revenue and Growth Rate (2017-2027)
6.5. Peripheral Vascular Disease
6.5.1. Global Peripheral Vascular Disease Revenue and Growth Rate (2017-2027)
7. Angiography Injectors Market, By Region
7.1. Introduction
7.2. Global Angiography Injectors Revenue and Market Share by Regions
7.2.1. Global Angiography Injectors Revenue by Regions (2017-2027)
7.3. North America Angiography Injectors by Countries
7.3.1. North America Angiography Injectors Revenue and Growth Rate (2017-2027)
7.3.2. North America Angiography Injectors Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Angiography Injectors by Countries
7.4.1. Europe Angiography Injectors Revenue and Growth Rate (2017-2027)
7.4.2. Europe Angiography Injectors Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Angiography Injectors by Countries
7.5.1. Asia-Pacific Angiography Injectors Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Angiography Injectors Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Angiography Injectors by Countries
7.6.1. South America Angiography Injectors Revenue and Growth Rate (2017-2027)
7.6.2. South America Angiography Injectors Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Angiography Injectors by Countries
7.7.1. Middle East and Africa Angiography Injectors Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Angiography Injectors Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bayer AG (Medrad Inc.)
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. GE Healthcare
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Vivid Imaging
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Bracco Imaging
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Ulrich
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Guerbet Group
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Nemoto Kyorindo
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Apollo RT
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Sino Medical-Device Technology
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Angiodynamics (Navilyst Medical)
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Angiography Injectors Market Forecast (2017-2027)
9.1. Global Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Angiography Injectors Market Forecast by Regions (2017-2027)
9.2.1. North America Angiography Injectors Market Forecast (2017-2027)
9.2.1.1. United States Angiography Injectors Market Forecast (2017-2027)
9.2.1.2. Canada Angiography Injectors Market Forecast (2017-2027)
9.2.1.3. Mexico Angiography Injectors Market Forecast (2017-2027)
9.2.2. Europe Angiography Injectors Market Forecast (2017-2027)
9.2.2.1. Germany Angiography Injectors Market Forecast (2017-2027)
9.2.2.2. France Angiography Injectors Market Forecast (2017-2027)
9.2.2.3. UK Angiography Injectors Market Forecast (2017-2027)
9.2.2.4. Russia Angiography Injectors Market Forecast (2017-2027)
9.2.2.5. Italy Angiography Injectors Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Angiography Injectors Market Forecast (2017-2027)
9.2.3. Asia-Pacific Angiography Injectors Market Forecast (2017-2027)
9.2.3.1. China Angiography Injectors Market Forecast (2017-2027)
9.2.3.2. Japan Angiography Injectors Market Forecast (2017-2027)
9.2.3.3. Korea Angiography Injectors Market Forecast (2017-2027)
9.2.3.4. India Angiography Injectors Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Angiography Injectors Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Angiography Injectors Market Forecast (2017-2027)
9.2.4. South America Angiography Injectors Market Forecast (2017-2027)
9.2.4.1. Brazil Angiography Injectors Market Forecast (2017-2027)
9.2.4.2. Argentina Angiography Injectors Market Forecast (2017-2027)
9.2.4.3. Columbia Angiography Injectors Market Forecast (2017-2027)
9.2.4.4. Rest of South America Angiography Injectors Market Forecast (2017-2027)
9.2.5. Middle East and Africa Angiography Injectors Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Angiography Injectors Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Angiography Injectors Market Forecast (2017-2027)
9.2.5.3. Egypt Angiography Injectors Market Forecast (2017-2027)
9.2.5.4. Nigeria Angiography Injectors Market Forecast (2017-2027)
9.2.5.5. South Africa Angiography Injectors Market Forecast (2017-2027)
9.2.5.6. Turkey Angiography Injectors Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Angiography Injectors Market Forecast (2017-2027)
9.3. Angiography Injectors Market Forecast by Type (2017-2027)
9.3.1. Angiography Injectors Forecast by Type (2017-2027)
9.3.2. Angiography Injectors Market Share Forecast by Type (2017-2027)
9.4. Angiography Injectors Market Forecast by Application (2017-2027)
9.4.1. Angiography Injectors Forecast by Application (2017-2027)
9.4.2. Angiography Injectors Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Angiography Injectors Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Angiography Injectors Revenue and Revenue Share by Type (2017-2018)
Figure Global Dual-head Revenue and Growth Rate (2017-2018)
Figure Global Single-head Revenue and Growth Rate (2017-2018)
Table Global Angiography Injectors Revenue and Revenue Share by Application (2017-2018)
Figure Global Cardiac Macrovascular Disease Revenue and Growth Rate (2017-2018)
Figure Global Central Nervous System Disease Revenue and Growth Rate (2017-2018)
Figure Global Peripheral Vascular Disease Revenue and Growth Rate (2017-2018)
Table Global Angiography Injectors Revenue by Regions (2017-2018)
Figure North America Angiography Injectors Growth Rate (2017-2018)
Figure North America Angiography Injectors Revenue and Growth Rate (2017-2018)
Figure North America Angiography Injectors by Countries (2017-2018)
Figure North America Angiography Injectors Revenue (Million USD) by Countries (2017-2018)
Figure United States Angiography Injectors Growth Rate (2017-2018)
Figure United States Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Angiography Injectors Growth Rate (2017-2018)
Figure Canada Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Angiography Injectors Growth Rate (2017-2018)
Figure Mexico Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Angiography Injectors Growth Rate (2017-2018)
Figure Europe Angiography Injectors Revenue and Growth Rate (2017-2018)
Figure Europe Angiography Injectors by Countries (2017-2018)
Figure Europe Angiography Injectors Revenue (Million USD) by Countries (2017-2018)
Figure Germany Angiography Injectors Growth Rate (2017-2018)
Figure Germany Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Angiography Injectors Growth Rate (2017-2018)
Figure France Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Angiography Injectors Growth Rate (2017-2018)
Figure UK Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Angiography Injectors Growth Rate (2017-2018)
Figure Russia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Angiography Injectors Growth Rate (2017-2018)
Figure Italy Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Angiography Injectors Growth Rate (2017-2018)
Figure Rest of Europe Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Angiography Injectors Growth Rate (2017-2018)
Figure Asia-Pacific Angiography Injectors Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Angiography Injectors by Countries (2017-2018)
Figure Asia-Pacific Angiography Injectors Revenue (Million USD) by Countries (2017-2018)
Figure China Angiography Injectors Growth Rate (2017-2018)
Figure China Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Angiography Injectors Growth Rate (2017-2018)
Figure Japan Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Angiography Injectors Growth Rate (2017-2018)
Figure Korea Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Angiography Injectors Growth Rate (2017-2018)
Figure India Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Angiography Injectors Growth Rate (2017-2018)
Figure Southeast Asia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angiography Injectors Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Angiography Injectors Growth Rate (2017-2018)
Figure South America Angiography Injectors Revenue and Growth Rate (2017-2018)
Figure South America Angiography Injectors by Countries (2017-2018)
Figure South America Angiography Injectors Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Angiography Injectors Growth Rate (2017-2018)
Figure Brazil Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Angiography Injectors Growth Rate (2017-2018)
Figure Argentina Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Angiography Injectors Growth Rate (2017-2018)
Figure Columbia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Angiography Injectors Growth Rate (2017-2018)
Figure Rest of South America Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Angiography Injectors Growth Rate (2017-2018)
Figure Middle East and Africa Angiography Injectors Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Angiography Injectors by Countries (2017-2018)
Figure Middle East and Africa Angiography Injectors Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Angiography Injectors Growth Rate (2017-2018)
Figure Saudi Arabia Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Angiography Injectors Growth Rate (2017-2018)
Figure United Arab Emirates Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Angiography Injectors Growth Rate (2017-2018)
Figure Egypt Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Angiography Injectors Growth Rate (2017-2018)
Figure Nigeria Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Angiography Injectors Growth Rate (2017-2018)
Figure South Africa Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Angiography Injectors Growth Rate (2017-2018)
Figure Turkey Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angiography Injectors Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angiography Injectors Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer AG (Medrad Inc.) Angiography Injectors Financial Overview
Table GE Healthcare Angiography Injectors Financial Overview
Table Vivid Imaging Angiography Injectors Financial Overview
Table Bracco Imaging Angiography Injectors Financial Overview
Table Ulrich Angiography Injectors Financial Overview
Table Guerbet Group Angiography Injectors Financial Overview
Table Nemoto Kyorindo Angiography Injectors Financial Overview
Table Apollo RT Angiography Injectors Financial Overview
Table Sino Medical-Device Technology Angiography Injectors Financial Overview
Table Angiodynamics (Navilyst Medical) Angiography Injectors Financial Overview
Figure Global Angiography Injectors Revenue (Millions USD) and Growth Rate (2018-2025)
Table Angiography Injectors Market Forecast by Regions (2018-2025)
Figure North America Angiography Injectors Market Forecast (2018-2025)
Figure United States Angiography Injectors Market Forecast (2018-2025)
Figure Canada Angiography Injectors Market Forecast (2018-2025)
Figure Mexico Angiography Injectors Market Forecast (2018-2025)
Figure Europe Angiography Injectors Market Forecast (2018-2025)
Figure Germany Angiography Injectors Market Forecast (2018-2025)
Figure France Angiography Injectors Market Forecast (2018-2025)
Figure UK Angiography Injectors Market Forecast (2018-2025)
Figure Russia Angiography Injectors Market Forecast (2018-2025)
Figure Italy Angiography Injectors Market Forecast (2018-2025)
Figure Rest of Europe Angiography Injectors Market Forecast (2018-2025)
Figure Asia-Pacific Angiography Injectors Market Forecast (2018-2025)
Figure China Angiography Injectors Market Forecast (2018-2025)
Figure Japan Angiography Injectors Market Forecast (2018-2025)
Figure Korea Angiography Injectors Market Forecast (2018-2025)
Figure India Angiography Injectors Market Forecast (2018-2025)
Figure Southeast Asia Angiography Injectors Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Angiography Injectors Market Forecast (2018-2025)
Figure South America Angiography Injectors Market Forecast (2018-2025)
Figure Brazil Angiography Injectors Market Forecast (2018-2025)
Figure Argentina Angiography Injectors Market Forecast (2018-2025)
Figure Columbia Angiography Injectors Market Forecast (2018-2025)
Figure Rest of South America Angiography Injectors Market Forecast (2018-2025)
Figure Middle East and Africa Angiography Injectors Market Forecast (2018-2025)
Figure Saudi Arabia Angiography Injectors Market Forecast (2018-2025)
Figure United Arab Emirates Angiography Injectors Market Forecast (2018-2025)
Figure Egypt Angiography Injectors Market Forecast (2018-2025)
Figure Nigeria Angiography Injectors Market Forecast (2018-2025)
Figure South Africa Angiography Injectors Market Forecast (2018-2025)
Figure Turkey Angiography Injectors Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Angiography Injectors Market Forecast (2018-2025)
Figure Global Angiography Injectors Forecast by Type (2018-2025)
Figure Global Angiography Injectors Market Share Forecast by Type (2018-2025)
Figure Global Angiography Injectors Forecast by Type (2018-2025)
Figure Global Angiography Injectors Forecast by Application (2018-2025)
Figure Global Angiography Injectors Market Share Forecast by Application (2018-2025)
Figure Global Angiography Injectors Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|